Why the study?
The association between fetal growth restriction in a first pregnancy and adverse maternal cardiovascular outcomes within 5 years postpartum required evaluation.
Population
Nulliparous women aged >=18 years without prior cardiovascular disease after singleton delivery (84,863 or 84,861 per matched group)
Comparison
Presence vs absence of fetal growth restriction
Design
Retrospective propensity-score matched study using a global federated health research network (TriNetX)
Follow-up
Within 5 years postpartum
Answers are grounded in this paper and cite their sources.
Retrospective study reveals increased five-year cardiovascular risk in women with fetal growth restriction during first pregnancy, suggesting early maternal cardiovascular vulnerability.
Objective To evaluate the association between fetal growth restriction (FGR) and adverse maternal cardiovascular outcomes within 5 years postpartum. Methods This was a retrospective study that used a global federated health research network (TriNetX) in which diagnoses are coded using the International Classification of Diseases, tenth revision, Clinical Modification system (ICD‐10‐CM). Nulliparous women aged ≥ 18 years, without prior cardiovascular disease and with a singleton pregnancy delivered between April 2006 and December 2020, were categorized by the presence or absence of FGR (ICD‐10‐CM: O36.5). 1:1 propensity‐score matching (PSM) was applied using two models: Model 1, matching for pre‐existing cardiovascular risk factors; and Model 2, matching for both pre‐existing and other pregnancy‐related cardiovascular risk factors. Cox regression proportional hazard models were used to estimate hazard ratios (HRs) with 95% CI for a maternal composite cardiovascular outcome including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke within 5 years postpartum, and for each of these components individually. Results After PSM, 84 863 women per group were analyzed in Model 1 and 84 861 per group in Model 2. FGR was associated with an increased risk of the composite cardiovascular outcome (Model 1: HR, 1.33 (95% CI, 1.16–1.52); Model 2: HR, 1.31 (95% CI, 1.15–1.50)), as well as with an increased risk of each of the components of the composite outcome individually: heart failure (Model 1: HR, 1.29 (95% CI, 1.08–1.54); Model 2: HR, 1.30 (95% CI, 1.09–1.56)), acute myocardial infarction (Model 1: HR, 1.55 (95% CI, 1.16–2.08); Model 2: HR, 1.53 (95% CI, 1.15–2.05)) and cerebral infarction/ischemic stroke (Model 1: HR, 1.38 (95% CI, 1.09–1.74); Model 2: HR, 1.33 (95% CI, 1.06–1.68)) within 5 years postpartum. Conclusions FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke, within 5 years postpartum. These findings suggest that FGR may be a marker of early cardiovascular vulnerability. However, residual confounding, particularly by unmeasured timing or severity of pre‐eclampsia, cannot be excluded. Also, FGR was identified using coding constructs based on electronic health records, which may include overlap with broader ‘suspected poor growth’ phenotypes such as small‐for‐gestational age, hence potentially diluting the observed associations. Earlier risk assessment and preventive strategies may help to reduce the risk of long‐term morbidity and mortality in this population.
No takes yet. Share an insight, caveat, or question.
Anand et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: